NYSE · Healthcare
GARTNER INC (IT)
As-reported financials and recent SEC filings for GARTNER INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$6.50B
Net income
$729.2M
Net margin
11.2%
Diluted EPS
$9.65
ROE
228.0%
P/E (TTM)
13.3×
Market cap
$9.04B
Debt / equity
9.3×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $6.50B | $6.27B | $5.91B | $5.48B | $4.73B |
| Gross profit | $4.44B | $4.24B | $4.00B | $3.78B | $3.29B |
| Operating income | $1.03B | $1.16B | $1.24B | $1.10B | $915.8M |
| Net income | $729.2M | $1.25B | $882.5M | $807.8M | $793.6M |
| Diluted EPS | $9.65 | $16.00 | $11.08 | $9.96 | $9.21 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-10
View on EDGAR →SCHEDULE 13G/A2026-06-03
View on EDGAR →42026-06-03
View on EDGAR →42026-06-02
View on EDGAR →42026-06-02
View on EDGAR →42026-06-02
View on EDGAR →42026-06-02
View on EDGAR →42026-06-02
View on EDGAR →Go deeper on IT
Search GARTNER INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.